once-weekly semaglutide in adults with overweight or obesity as a GLP-1 Agonist: A Breakthrough Treatment Once‑Weekly Semaglutide in Adults with

10.1002/ctm2.372 Clin Transl Med

It mimics GLP-1 and is approved for long-term weight management in adults and children aged 12 and older

Confidence Boost and Improved Daily Well-Being As weight begins to drop, patients often notice significant improvements in self-esteem, daily comfort, and overall well-being

In hepatocytes, triiodothyronine (T3) binding to THR- stimulates -oxidation, increases LDL receptor expression, improves mitochondrial function in hepatic cells, boosts very-low-density lipoprotein (VLDL) secretion, and enhances reverse cholesterol transport, thereby reducing lipotoxicity and inflammation [3, 16]

It builds strength and lean muscle